A dose-escalation and pharmacokinetic study of subcutaneously administered recombinant human interleukin 12 and its biological effects in Japanese patients with advanced malignancies.
about
Focused ultrasound-induced blood-brain barrier opening to enhance interleukin-12 delivery for brain tumor immunotherapy: a preclinical feasibility study.Cloning and characterization of an adenoviral vector for highly efficient and doxycycline-suppressible expression of bioactive human single-chain interleukin 12 in colon cancer.Diagnostic role of serum interleukin-18 in gastric cancer patients.Interleukin-12: an update on its immunological activities, signaling and regulation of gene expressionSingle low-dose rHuIL-12 safely triggers multilineage hematopoietic and immune-mediated effects.
P2860
A dose-escalation and pharmacokinetic study of subcutaneously administered recombinant human interleukin 12 and its biological effects in Japanese patients with advanced malignancies.
description
2000 nî lūn-bûn
@nan
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
2000年论文
@zh
2000年论文
@zh-cn
name
A dose-escalation and pharmaco ...... ts with advanced malignancies.
@en
type
label
A dose-escalation and pharmaco ...... ts with advanced malignancies.
@en
prefLabel
A dose-escalation and pharmaco ...... ts with advanced malignancies.
@en
P2093
P1476
A dose-escalation and pharmaco ...... ts with advanced malignancies.
@en
P2093
Kinouchi T
Kiyohara Y
P304
P407
P577
2000-07-01T00:00:00Z